amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension

RxCUI: 2059184
RxNorm name: amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension
Display name: amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension
Full name: amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ARIKAYCE	AMIKACIN	Insmed Incorporated	499ab990-2b21-474f-aaba-d86388965f40	2026-06-29	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2059184

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
499ab990-2b21-474f-aaba-d86388965f40	amikacin liposomal 590 MG in 8.4 ML Inhalation Suspension	PSN	14	These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE ® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S. Approval: 2018 LIMITED POPULATION	20251229
499ab990-2b21-474f-aaba-d86388965f40	amikacin liposomal 590 MG per 8.4 ML Inhalation Suspension	SY	14	These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE ® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S. Approval: 2018 LIMITED POPULATION	20251229
499ab990-2b21-474f-aaba-d86388965f40	amikacin liposomal 70.3 MG/ML Inhalation Suspension	SCD	14	These highlights do not include all the information needed to use ARIKAYCE safely and effectively. See full prescribing information for ARIKAYCE. ARIKAYCE ® (amikacin liposome inhalation suspension), for oral inhalation use Initial U.S. Approval: 2018 LIMITED POPULATION	20251229